Predictors of language regression and its association with subsequent communication development in children with autism.


Journal

Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361

Informations de publication

Date de publication:
11 2022
Historique:
accepted: 26 11 2021
pubmed: 1 2 2022
medline: 25 10 2022
entrez: 31 1 2022
Statut: ppublish

Résumé

Language regression, broadly defined as the loss of acquired language skills in early childhood, is a distinctive feature of autism. Little is known about the factors underlying regression or the prognosis of children who exhibit regression. We examine potential predictors of language regression and test its association with language development in a prospective longitudinal sample of children with autism spectrum disorder (ASD) from diagnosis to age 10 years. We analysed data from Pathways in ASD, a prospective longitudinal study of 421 children enrolled around the time of an autism diagnosis between 2 and 5 years. Autism Diagnostic Interview-Revised data were available for 408 children, of whom 90 (22%) were classified as having language regression. Demographic and other health factors including caregiver education, family income, child sex, reported seizures, and age of enrolment did not differ between children with and without language regression. Children with language regression walked earlier and attained first words sooner than those without regression. However, both groups attained phrase speech at comparable ages. Those with regression exhibited greater delays in expressive and receptive communication over the follow-up period, although this effect was attenuated when accounting for baseline differences in motor and cognitive ability. Overall, those with language regression continued to exhibit expressive but not receptive communication delay compared to those without regression. Communication trajectories were heterogeneous to age 10 years, irrespective of regression status. Although language regression can be alarming, our findings confirm that its occurrence does not necessarily foreshadow worse developmental outcomes relative to those without regression. Although a discrepancy in age-equivalent communication skills may persist, this can be expected to be of less practical importance with rising average levels of skills. Future studies need to account for the significant variability in language trajectories by considering factors beyond developmental regression.

Sections du résumé

BACKGROUND
Language regression, broadly defined as the loss of acquired language skills in early childhood, is a distinctive feature of autism. Little is known about the factors underlying regression or the prognosis of children who exhibit regression. We examine potential predictors of language regression and test its association with language development in a prospective longitudinal sample of children with autism spectrum disorder (ASD) from diagnosis to age 10 years.
METHODS
We analysed data from Pathways in ASD, a prospective longitudinal study of 421 children enrolled around the time of an autism diagnosis between 2 and 5 years. Autism Diagnostic Interview-Revised data were available for 408 children, of whom 90 (22%) were classified as having language regression.
RESULTS
Demographic and other health factors including caregiver education, family income, child sex, reported seizures, and age of enrolment did not differ between children with and without language regression. Children with language regression walked earlier and attained first words sooner than those without regression. However, both groups attained phrase speech at comparable ages. Those with regression exhibited greater delays in expressive and receptive communication over the follow-up period, although this effect was attenuated when accounting for baseline differences in motor and cognitive ability. Overall, those with language regression continued to exhibit expressive but not receptive communication delay compared to those without regression. Communication trajectories were heterogeneous to age 10 years, irrespective of regression status.
CONCLUSIONS
Although language regression can be alarming, our findings confirm that its occurrence does not necessarily foreshadow worse developmental outcomes relative to those without regression. Although a discrepancy in age-equivalent communication skills may persist, this can be expected to be of less practical importance with rising average levels of skills. Future studies need to account for the significant variability in language trajectories by considering factors beyond developmental regression.

Identifiants

pubmed: 35098539
doi: 10.1111/jcpp.13565
pmc: PMC9786608
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1243-1251

Subventions

Organisme : Kids Brain Health Network
Organisme : Azrieli Centre for Autism Research at the Montreal Neurological Institute, McGill University
Organisme : King's College London
ID : 204823/Z/16/Z
Organisme : Fonds de Recherche du Québec - Santé
Organisme : Institute of Human Development, Child and Youth Health
Organisme : Sinneave Family Foundation
Organisme : South London and Maudsley NHS Foundation Trust
Organisme : Autism Speaks
Pays : United States
Organisme : CIHR
Pays : Canada

Informations de copyright

© 2022 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Références

J Am Acad Child Psychiatry. 1985 Mar;24(2):191-6
pubmed: 3989162
J Consult Clin Psychol. 2012 Jun;80(3):477-89
pubmed: 22506796
Neurobiol Lang (Camb). 2020;1(1):33-53
pubmed: 32656537
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
J Speech Lang Hear Res. 2016 Feb;59(1):143-54
pubmed: 26502110
J Child Psychol Psychiatry. 2020 Jul;61(7):826-835
pubmed: 31429087
J Autism Dev Disord. 2010 Jan;40(1):54-62
pubmed: 19633940
J Autism Dev Disord. 1987 Jun;17(2):273-87
pubmed: 3610999
Arch Gen Psychiatry. 2005 Aug;62(8):889-95
pubmed: 16061766
Autism. 2005 Dec;9(5):461-86
pubmed: 16287700
Pediatrics. 2012 May;129(5):e1112-20
pubmed: 22473372
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Neurosci Biobehav Rev. 2019 Jul;102:208-220
pubmed: 31059729
J Child Psychol Psychiatry. 2004 Jul;45(5):936-55
pubmed: 15225337
J Child Psychol Psychiatry. 2011 Jul;52(7):753-60
pubmed: 21410473
BMJ. 2020 Jan 28;368:l6880
pubmed: 31992555
Ment Retard Dev Disabil Res Rev. 2004;10(2):139-43
pubmed: 15362172
Mol Autism. 2013 May 15;4(1):12
pubmed: 23675638
Autism Res. 2016 Sep;9(9):993-1001
pubmed: 26692550
Pediatr Neurol. 1996 Oct;15(3):217-23
pubmed: 8916159
Jpn J Psychiatry Neurol. 1987 Jun;41(2):237-45
pubmed: 3437611
J Child Psychol Psychiatry. 2014 Dec;55(12):1354-62
pubmed: 24889883
J Paediatr Child Health. 2015 Jan;51(1):61-4
pubmed: 25586846
J Autism Dev Disord. 2013 Apr;43(4):817-28
pubmed: 22855372
Neurosci Biobehav Rev. 2019 Jul;102:24-55
pubmed: 30917924
Dev Med Child Neurol. 2003 Aug;45(8):508-14
pubmed: 12882529
Autism Res. 2008 Dec;1(6):320-8
pubmed: 19360687
J Am Acad Child Adolesc Psychiatry. 1990 Nov;29(6):863-72
pubmed: 2273012
Brain Dev. 2010 Oct;32(9):746-52
pubmed: 20637551
Pediatrics. 2013 Apr;131(4):e1128-34
pubmed: 23460690
J Am Acad Child Adolesc Psychiatry. 2017 Aug;56(8):659-668
pubmed: 28735695
Autism Res. 2020 Jan;13(1):145-156
pubmed: 31468744
J Child Psychol Psychiatry. 2009 Jul;50(7):843-52
pubmed: 19527315
Semin Pediatr Neurol. 2017 Nov;24(4):292-300
pubmed: 29249509
Neurosci Biobehav Rev. 2019 May;100:296-304
pubmed: 30885812
J Neurodev Disord. 2017 Sep 13;9(1):34
pubmed: 28903722
Am J Psychiatry. 2000 Dec;157(12):1980-7
pubmed: 11097964

Auteurs

Andrew Pickles (A)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Nicola Wright (N)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Mandy Steiman (M)

Azrieli Centre for Autism Research, Montreal Neurological Hospital, McGill University, Montreal, QC, Canada.

Eric Duku (E)

McMaster University, Hamilton, ON, Canada.

Teresa Bennett (T)

McMaster University, Hamilton, ON, Canada.

Stelios Georgiades (S)

McMaster University, Hamilton, ON, Canada.

Connor M Kerns (CM)

University of British Columbia, Vancouver, BC, Canada.

Pat Mirenda (P)

University of British Columbia, Vancouver, BC, Canada.

Isabel M Smith (IM)

Dalhousie University, Halifax, NS, Canada.

Wendy J Ungar (WJ)

Hospital for Sick Children Research Institute, University of Toronto, Toronto, ON, Canada.

Tracy Vaillancourt (T)

University of Ottawa, Ottawa, ON, Canada.

Charlotte Waddell (C)

University of British Columbia, Vancouver, BC, Canada.

Anat Zaidman-Zait (A)

Tel Aviv University, Tel Aviv, Israel.

Lonnie Zwaigenbaum (L)

University of Alberta, Edmonton, AB, Canada.

Peter Szatmari (P)

Hospital for Sick Children Research Institute, University of Toronto, Toronto, ON, Canada.

Mayada Elsabbagh (M)

Azrieli Centre for Autism Research, Montreal Neurological Hospital, McGill University, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH